Grammy-winning soul vocalist D’Angelo died on October 14 at 51 years old after a personal fight with pancreatic malignancy.
“The shining star of our family has faded away for us in this life,” his relatives stated. “After a prolonged and courageous battle with the disease, we are deeply saddened to announce that D’Angelo, known to his followers around the world as D’Angelo, has been called home.”
D’Angelo left an indelible mark on music with his innovative modern soul style and partnerships with renowned musicians.
He released his first record, “Brown Sugar,” in the mid-nineties to immediate acclaim. The album achieved the fourth spot on the R&B charts, earned platinum status soon after, and received several Grammy nominations.
However, it was his second album, “Voodoo,” in 2000 that propelled his artistic journey into the stratosphere. The record debuted at No. 1 on each of the R&B charts and the main album chart. He won two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”
The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a sex symbol, albeit a hesitant one, in the public consciousness. The personal depiction showed the singer, notably stripped down to his midsection, performing straight into the lens.
D’Angelo retreated from the public eye after putting out Voodoo and openly battled with substance abuse. In 2005, he was involved in a serious car crash that put him in grave health.
Over ten years later, his third and final album, “Black Messiah” (2014), reaffirmed his enduring appeal with a further top chart entry on the soul music rankings and a Grammy for Best R&B Album.
Again, in his own mysterious way, D’Angelo made only a few public outings in the subsequent period.
The singer was scheduled as a top act for the 2025 music event, but his appearance was called off, citing an “unforeseen medical delay.”
Although details are sparse about D’Angelo’s health in the months leading up to his passing, he had reportedly been hospitalized for months and in palliative care for two weeks.
D’Angelo’s passing is a clear example of the devastating effects of pancreatic cancer, one of the deadliest and hardest to prevent forms of the disease, on a brilliant talent whose life was cut short.
“We are grieved that he can only leave dear memories with his loved ones, but we are forever thankful for the heritage of extraordinarily moving music he has left us,” his family said.
Pancreatic malignancy impacts the digestive organ, a small organ that generates insulin and plays an essential role in digestion, among additional roles. The position and dimensions of the pancreas in the human system make it more difficult to identify cancer.
Although pancreatic cancer makes up only about 3% of malignancy cases each year in the U.S., it is responsible for seven percent of cancer deaths.
Nearly seventy thousand individuals will be diagnosed with pancreatic cancer and roughly fifty-two thousand will succumb to the illness in 2025.
“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have few and poor treatment options, and a smaller window to make a significant difference on the lives of people,” said a cancer specialist.
Because pancreatic cancer seldom produces initial signs, it’s frequently diagnosed only after the disease is late-stage. Although a patient has symptoms they are usually nonspecific and may be mistaken for a several everyday ailments.
“As of yet, there is no good way to identify this malignancy in the initial phases, apart from paying attention to physical changes and consulting your physician if there are new or unusual signs,” said a health expert.
Frequent indicators of this disease encompass:
At age 51, D’Angelo’s demise is an exception, as pancreatic cancer is typically found in adults in the 65 to 75 range. However, numerous malignancies, such as pancreatic cancer, have become more common in younger adults.
“Pancreatic cancer identified before the age of 50 is deemed uncommon, yet concerningly, clinicians are noticing a rising count of younger patients suffering from this condition,” commented a specialist.
Without effective detection methods for pancreatic cancer, experts emphasized the importance of understanding your relatives’ cancer history. Certain contributing elements, such as smoking and obesity also play a role in the onset of this disease.
African Americans have the highest incidence of pancreatic cancer in the U.S. and are more prone to be found to have untreatable disease.
“The first step toward reducing one’s chance of pancreatic cancer is understanding individual susceptibility. People should review their genetic background, genetic background, and medical conditions, such as diabetes, chronic pancreatitis, or overweight that may increase their vulnerability,” advised a medical professional.
Hereditary elements are linked to as much as 10% of all pancreatic cancer cases. If a relative in your family has had this disease, you may want to consider DNA analysis.
“For people with a family history of this condition or those having elevated risk genetic mutations, screening may involve advanced imaging such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to detect initial alterations in the pancreas,” he clarified.
For those wishing to reduce their risk, lifestyle changes may make a difference. The most effective step you can take to reduce your susceptibility of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.
Excessive drinking is associated with pancreas inflammation, a risk factor for this malignancy, so reducing or avoiding drinks may assist lower your chance.
Managing your body mass or shedding pounds may also help reduce your risk. Individuals with obesity are 20% more likely to get this disease. This malignancy also occurs more often in those with blood sugar issues, and reducing weight can also reduce the chance of type 2 diabetes.
In spite of pancreatic cancer’s grim outlook, there is still hope.
“We are doing better with treatments and more recent mixed drug treatments. There are developing targeted therapies that already are making an impact,” said a expert.
For numerous individuals, however, education about this rare but {dev
A tech journalist and gaming enthusiast with over a decade of experience covering digital trends and innovations.